SCHEMBL8360778

SCHEMBL8360778

Bc1cc(-c2ccccn2)cn(-c2cccnc2)c1=O

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.51
GRIA1 P42261 1/20 0.49
GRIA3 P42263 1/20 0.49
PDE4D Q08499 1/20 0.49
GRM5 P41594 5/20 0.40
HTT P42858 1/20 0.38
MAPT P10636 1/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
CYP2E1 P05181 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360380 0.89 GRIA1 (0.59) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL1881024 0.85 CYP2A6 (0.51) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL1880125 0.84 GRIA1 (0.60) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL1881066 0.82 GRIA1 (0.58) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL8360384 0.81 SMN1; SMN2 (0.47) CYP2A6GRIA1GRIA3PDE4DMAPT
SCHEMBL1889436 0.80 GRIA1 (0.61) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL1888734 0.80 GRIA1 (0.58) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL1884727 0.79 GRIA1 (0.55) CYP2A6GRIA1GRIA3PDE4DGRM5
SCHEMBL1883070 0.79 GRIA1 (0.52) CYP2A6GRIA1GRIA3PDE4DCYP2C9
SCHEMBL1884597 0.79 GRIA1 (0.52) CYP2A6GRIA1GRIA3PDE4DMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2177520-A1 1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors Eisai R&D Management Co., Ltd. (JP) 2010-04-21 EP disclosed
EP-2053041-A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease Eisai R&D Management Co., Ltd. (JP) 2009-04-29 EP disclosed
EP-1300396-B1 1,2-DIHYDROPYRIDINE COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF EISAI R&D MAN CO LTD (JP) 2009-01-14 EP disclosed
WO-2003047577-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING DIHYDROPYRIDINONE COMPOUNDS AND AN IMMUNOREGULATORY OR AN ANTIINFLAMMATORY AGENT AND THEIR USES EISAI CO LTD (JP) 2003-06-12 WO disclosed